Evidence map›Paper›PMID 42450193›Full record

ArticleInternational journal of molecular sciences2026

Hybrid Approach to Protein-Protein Complex Affinity Prediction Based on Language Models and Molecular Dynamics.

Elizaveta A Bogdanova, Artem V Chernukhin, Alexey K Shaytan

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elizaveta A BogdanovaAI Centre and Department of Biology, Lomonosov Moscow State University, Moscow 119991, Russia.ORCID 0009-0002-4019-157X
Artem V ChernukhinDepartment of Information and Computer Technologies, Mendeleev University of Chemical Technology of Russia, Moscow 125047, Russia.
Alexey K ShaytanAI Centre and Department of Biology, Lomonosov Moscow State University, Moscow 119991, Russia.

Funding

The Ministry of Economic Development of the Russian Federation 139-15-2025-012
6 · The paper itself

Abstract

Protein-protein and protein-peptide interactions are fundamental to biological processes, making the accurate prediction of their binding affinity crucial for drug design and mutational analysis. Here, we develop HyBind-NN, a multimodal graph neural network that integrates protein language models (PLMs) with 3D structural and dynamic datasets to predict protein-protein and protein-peptide affinity. First, we demonstrate that combining ESM-2 sequence embeddings with precise 3D Voronoi spatial geometry enables accurate affinity predictions across diverse structural datasets. Next, we show that the inherent limitations of static rigid-body structures can be mitigated through a multi-task learning framework. By utilizing residue-level root mean square fluctuations (RMSF) derived from molecular dynamics (MD) as an auxiliary training target, the model implicitly learns to capture the conformational entropy of flexible peptides without requiring computationally expensive MD simulations during inference. In our benchmarking study, we observe that this multimodal architecture outperforms both purely sequence-based and strictly structural state-of-the-art algorithms, achieving a mean absolute error of 0.89 for pK

Indexed as

Molecular Dynamics SimulationProteinsAlgorithmsGraph Neural NetworksPrediction AlgorithmsProtein BindingProtein ConformationProteinsbinding affinity predictiondeep learningmolecular dynamicsprotein language modelsprotein–protein interactionsstructural bioinformaticsVoronoi tessellation

Identifiers

PMID42450193
PMCPMC13361561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.